Pub Date : 2023-02-08eCollection Date: 2023-03-01DOI: 10.1097/PR9.0000000000001067
Cassie Higgins, Saurab Sharma, Inosha Bimali, Tim G Hales, Paul A Cameron, Blair H Smith, Lesley A Colvin
Introduction: The World Health Organization recognizes chronic pain as a global public health concern; however, there is a bias towards research conducted in relatively affluent nations. There is a dearth of large-scale epidemiological studies in Nepal using rigorously validated, cross-culturally adapted instruments.
Objectives: The aim of this study was to examine the prevalence of both chronic pain and chronic pain of predominantly neuropathic origin and their associations with a range of sociodemographic and psychosocial characteristics.
Methods: We conducted a cross-sectional study of adults (≥18 years) in all households in Ranipani, Baluwa Village Development Committee, Nepal. All adults (n = 887) were approached, and those consenting, who met the inclusion criteria (n = 520, 58.6%), participated. Questionnaires validated in Nepali were used to examine several constructs: demographics; chronic pain; neuropathic pain; pain catastrophizing; resilience, pain intensity; pain interference; sleep disturbance; and depression.
Results: The point prevalence of chronic pain was 53.3% (n = 277). The point prevalence of chronic pain of predominantly neuropathic origin was 12.7% (n = 66). Chronic pain was associated with female gender, older age, and manual labour occupations. Using standardized scoring techniques, compared with available population estimates from other countries, those with chronic pain were associated with lower pain intensity and resilience scores and higher pain catastrophizing, pain interference, and depression scores.
Conclusion: These findings are broadly comparable to epidemiological studies from other countries, and these indicate areas for targeting interventions (eg, occupational and mental health). For comparison, more data are needed, from larger population samples in this region.
{"title":"Cross-sectional study examining the epidemiology of chronic pain in Nepal.","authors":"Cassie Higgins, Saurab Sharma, Inosha Bimali, Tim G Hales, Paul A Cameron, Blair H Smith, Lesley A Colvin","doi":"10.1097/PR9.0000000000001067","DOIUrl":"10.1097/PR9.0000000000001067","url":null,"abstract":"<p><strong>Introduction: </strong>The World Health Organization recognizes chronic pain as a global public health concern; however, there is a bias towards research conducted in relatively affluent nations. There is a dearth of large-scale epidemiological studies in Nepal using rigorously validated, cross-culturally adapted instruments.</p><p><strong>Objectives: </strong>The aim of this study was to examine the prevalence of both chronic pain and chronic pain of predominantly neuropathic origin and their associations with a range of sociodemographic and psychosocial characteristics.</p><p><strong>Methods: </strong>We conducted a cross-sectional study of adults (≥18 years) in all households in Ranipani, Baluwa Village Development Committee, Nepal. All adults (n = 887) were approached, and those consenting, who met the inclusion criteria (n = 520, 58.6%), participated. Questionnaires validated in Nepali were used to examine several constructs: demographics; chronic pain; neuropathic pain; pain catastrophizing; resilience, pain intensity; pain interference; sleep disturbance; and depression.</p><p><strong>Results: </strong>The point prevalence of chronic pain was 53.3% (n = 277). The point prevalence of chronic pain of predominantly neuropathic origin was 12.7% (n = 66). Chronic pain was associated with female gender, older age, and manual labour occupations. Using standardized scoring techniques, compared with available population estimates from other countries, those with chronic pain were associated with lower pain intensity and resilience scores and higher pain catastrophizing, pain interference, and depression scores.</p><p><strong>Conclusion: </strong>These findings are broadly comparable to epidemiological studies from other countries, and these indicate areas for targeting interventions (eg, occupational and mental health). For comparison, more data are needed, from larger population samples in this region.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 2","pages":"e1067"},"PeriodicalIF":4.8,"publicationDate":"2023-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e6/a9/painreports-8-e1067.PMC9928837.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10825716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-16eCollection Date: 2023-01-01DOI: 10.1097/PR9.0000000000001063
Tonya M Palermo, Karen Deborah Davis, Didier Bouhassira, Robert W Hurley, Joel D Katz, Francis J Keefe, Michael Schatman, Dennis C Turk, David Yarnitsky
{"title":"Promoting inclusion, diversity, and equity in pain science.","authors":"Tonya M Palermo, Karen Deborah Davis, Didier Bouhassira, Robert W Hurley, Joel D Katz, Francis J Keefe, Michael Schatman, Dennis C Turk, David Yarnitsky","doi":"10.1097/PR9.0000000000001063","DOIUrl":"10.1097/PR9.0000000000001063","url":null,"abstract":"","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1063"},"PeriodicalIF":3.4,"publicationDate":"2023-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10623264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/PR9.0000000000001058
Alice Munk, Henrik Børsting Jacobsen, Julie Schnur, Guy Montgomery, Silje Endresen Reme
Introduction: Women who undergo breast cancer surgery risk suffering from postsurgical pain long after their surgery. Still, research on postsurgical pain in the subacute phase has been neglected.
Objective: This study aims to investigate the incidence, intensity, unpleasantness, and presurgical predictors of acute and subacute postsurgical pain after breast cancer surgery.
Methods: The study used an observational design through secondary analyses of the control group in a randomized controlled trial. Data from 102 women undergoing breast cancer surgery were included. Levels of acute and subacute pain intensity and unpleasantness were measured using 100 mm Visual Analogue Scales on the day of surgery and 4 weeks postsurgery. Linear regression analyses were performed to identify presurgical biopsychosocial predictors of acute and subacute postsurgical pain.
Results: Average levels of postsurgical pain intensity and unpleasantness were as follows: 22.7 mm for acute pain intensity, 19.0 mm for acute pain unpleasantness, 10.3 mm for subacute pain intensity, and 11.7 mm for subacute pain unpleasantness. Pain expectancy predicted acute pain intensity (R2 = 0.04, p = 0.047) and acute unpleasantness (R2 = 0.06, p = 0.02). Perceived social support inversely predicted acute pain unpleasantness (R2 = 0.04, p = 0.014).
Conclusion: Mild and moderate acute pain intensity and unpleasantness are common after breast cancer surgery, whereas levels of subacute pain intensity and unpleasantness are low. Pain expectancy predicts acute postsurgical pain intensity and unpleasantness, whereas expected social support inversely predicts acute postsurgical pain unpleasantness.
导读:接受乳腺癌手术的女性在手术后很长一段时间内都面临着术后疼痛的风险。然而,对亚急性期术后疼痛的研究一直被忽视。目的:本研究旨在探讨乳腺癌术后急性和亚急性疼痛的发生率、强度、不愉快程度及术前预测因素。方法:采用观察设计,采用随机对照试验对对照组进行二次分析。研究数据来自102名接受乳腺癌手术的女性。在手术当天和术后4周使用100毫米视觉模拟量表测量急性和亚急性疼痛强度和不愉快程度。进行线性回归分析以确定手术前急性和亚急性术后疼痛的生物心理社会预测因素。结果:术后疼痛强度和不愉快的平均水平为:急性疼痛强度22.7 mm,急性疼痛不愉快19.0 mm,亚急性疼痛强度10.3 mm,亚急性疼痛不愉快11.7 mm。疼痛预期预测急性疼痛强度(R2 = 0.04, p = 0.047)和急性不愉快(R2 = 0.06, p = 0.02)。感知社会支持与急性疼痛不愉快呈负相关(R2 = 0.04, p = 0.014)。结论:乳腺癌术后轻、中度急性疼痛和不愉快发生率较高,而亚急性疼痛和不愉快发生率较低。疼痛预期预测急性术后疼痛强度和不愉快,而预期的社会支持与急性术后疼痛不愉快呈负相关。
{"title":"Acute and subacute postsurgical pain in women with breast cancer: incidence and associations with biopsychosocial predictors-a secondary analysis of a randomized controlled trial.","authors":"Alice Munk, Henrik Børsting Jacobsen, Julie Schnur, Guy Montgomery, Silje Endresen Reme","doi":"10.1097/PR9.0000000000001058","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001058","url":null,"abstract":"<p><strong>Introduction: </strong>Women who undergo breast cancer surgery risk suffering from postsurgical pain long after their surgery. Still, research on postsurgical pain in the subacute phase has been neglected.</p><p><strong>Objective: </strong>This study aims to investigate the incidence, intensity, unpleasantness, and presurgical predictors of acute and subacute postsurgical pain after breast cancer surgery.</p><p><strong>Methods: </strong>The study used an observational design through secondary analyses of the control group in a randomized controlled trial. Data from 102 women undergoing breast cancer surgery were included. Levels of acute and subacute pain intensity and unpleasantness were measured using 100 mm Visual Analogue Scales on the day of surgery and 4 weeks postsurgery. Linear regression analyses were performed to identify presurgical biopsychosocial predictors of acute and subacute postsurgical pain.</p><p><strong>Results: </strong>Average levels of postsurgical pain intensity and unpleasantness were as follows: 22.7 mm for acute pain intensity, 19.0 mm for acute pain unpleasantness, 10.3 mm for subacute pain intensity, and 11.7 mm for subacute pain unpleasantness. Pain expectancy predicted acute pain intensity (R<sup>2</sup> = 0.04, <i>p</i> = 0.047) and acute unpleasantness (R<sup>2</sup> = 0.06, <i>p</i> = 0.02). Perceived social support inversely predicted acute pain unpleasantness (R<sup>2</sup> = 0.04, <i>p</i> = 0.014).</p><p><strong>Conclusion: </strong>Mild and moderate acute pain intensity and unpleasantness are common after breast cancer surgery, whereas levels of subacute pain intensity and unpleasantness are low. Pain expectancy predicts acute postsurgical pain intensity and unpleasantness, whereas expected social support inversely predicts acute postsurgical pain unpleasantness.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1058"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10623263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/PR9.0000000000001060
Cosima Locher, Andreas Wörner, Maria Carlander, Joe Kossowsky, Julia Dratva, Helen Koechlin
Introduction: Chronic pain is a prevalent, yet underrecognized, condition in children and adolescents. A biopsychosocial framework has been widely adopted over the past decades and resulted in a new pain classification in the International Classification of Diseases, 11th revision (ICD-11). Nevertheless, little is known about pediatricians' pain concepts.
Objectives: We explored pain concepts of Swiss pediatricians by means of a qualitative analysis.
Method: A cross-sectional online survey was sent to clinically active Swiss pediatricians registered with the Swiss Society for Pediatrics. A case vignette of a girl with chronic musculoskeletal pain was presented and pediatricians were asked (1) what they think caused the pain, and (2) how they would explain the pain to the patient and their family. Structuring content analysis was applied to describe major themes within the answers.
Results: The following main categories emerged: psychological factors, biological factors, unclear etiology, social context, disorder specific, and multifactorial. Most pediatricians reported the belief that psychological factors explained the pain. However, when explaining the pain to the patient, biological factors were reported most often.
Conclusion: There is a discrepancy between pediatricians' conviction that chronic pain is mostly explained by psychological factors and their exploratory model towards patients that focuses on biological factors. Promoting the biopsychosocial framework of chronic pain is key to ensure timely and effective treatment. The new pain classification in the ICD-11 has the potential to increase the use of the biopsychosocial model.
{"title":"Chronic pain concepts of pediatricians: a qualitative survey.","authors":"Cosima Locher, Andreas Wörner, Maria Carlander, Joe Kossowsky, Julia Dratva, Helen Koechlin","doi":"10.1097/PR9.0000000000001060","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001060","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic pain is a prevalent, yet underrecognized, condition in children and adolescents. A biopsychosocial framework has been widely adopted over the past decades and resulted in a new pain classification in the International Classification of Diseases, 11th revision (ICD-11). Nevertheless, little is known about pediatricians' pain concepts.</p><p><strong>Objectives: </strong>We explored pain concepts of Swiss pediatricians by means of a qualitative analysis.</p><p><strong>Method: </strong>A cross-sectional online survey was sent to clinically active Swiss pediatricians registered with the Swiss Society for Pediatrics. A case vignette of a girl with chronic musculoskeletal pain was presented and pediatricians were asked (1) what they think caused the pain, and (2) how they would explain the pain to the patient and their family. Structuring content analysis was applied to describe major themes within the answers.</p><p><strong>Results: </strong>The following main categories emerged: psychological factors, biological factors, unclear etiology, social context, disorder specific, and multifactorial. Most pediatricians reported the belief that psychological factors explained the pain. However, when explaining the pain to the patient, biological factors were reported most often.</p><p><strong>Conclusion: </strong>There is a discrepancy between pediatricians' conviction that chronic pain is mostly explained by psychological factors and their exploratory model towards patients that focuses on biological factors. Promoting the biopsychosocial framework of chronic pain is key to ensure timely and effective treatment. The new pain classification in the ICD-11 has the potential to increase the use of the biopsychosocial model.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1060"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/02/47/painreports-8-e1060.PMC9845015.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10623262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/PR9.0000000000001053
Helen Koechlin, Carolina Donado, Cosima Locher, Joe Kossowsky, Francesca Lionetti, Michael Pluess
Introduction: Sensory processing sensitivity (SPS) describes a genetically influenced trait characterized by greater depth of information processing, lower sensory threshold, and ease of overstimulation. It is hypothesized that SPS plays a crucial role in the context of chronic pain.Objectives: This exploratory study examined SPS as a correlate of pain intensity and pain-related disability in a sample of adolescents reporting chronic pain.
Methods: Adolescents reporting chronic pain were contacted through social media and through specialized pain clinics. Participants completed online questionnaires on their levels of SPS, pain features, emotion regulation, and quality of life. A series of analysis of variances (ANOVAs) were calculated to detect differences between 3 SPS groups (ie, high, medium, and low sensitivity) regarding emotion regulation, quality of life, and pain features. Multiple linear regressions were conducted to predict pain intensity, pain-related disability, and quality of life.
Results: In total, 103 participants completed the survey (68.9% female, Mage 17.9). Back pain was the most frequently reported pain location. Proportion of highly sensitive individuals was large (45.68%). The ANOVA revealed significant differences between sensitivity groups related to quality-of-life subscales, namely, for physical (F(2, 100) = 7.42, P < 0.001), emotional (F(2, 100) = 6.11, P < 0.001), and school functioning (F(2, 100) = 3.75, P = 0.03). High sensitivity was not predictive of pain but of health-related quality of life.
Conclusions: Our results indicate that SPS is an important and prevalent characteristic to consider in the context of chronic pain in adolescents, specifically regarding the quality of life.
简介:感觉加工敏感性(SPS)描述了一种受遗传影响的特征,其特征是信息加工深度更大,感觉阈值更低,易于过度刺激。据推测,SPS在慢性疼痛中起着至关重要的作用。目的:本探索性研究在报告慢性疼痛的青少年样本中检验了SPS与疼痛强度和疼痛相关残疾的相关性。方法:通过社交媒体和专门的疼痛诊所联系报告慢性疼痛的青少年。参与者完成了关于SPS水平、疼痛特征、情绪调节和生活质量的在线问卷。计算一系列方差分析(ANOVAs),以检测3个SPS组(即高、中、低敏感组)在情绪调节、生活质量和疼痛特征方面的差异。采用多元线性回归预测疼痛强度、疼痛相关残疾和生活质量。结果:共103名参与者完成了调查(68.9%为女性,17.9%为男性)。背部疼痛是最常见的疼痛部位。高敏感个体比例较大(45.68%)。方差分析显示,与生活质量亚量表相关的敏感组之间存在显著差异,即身体(F(2,100) = 7.42, P < 0.001),情绪(F(2,100) = 6.11, P < 0.001)和学校功能(F(2,100) = 3.75, P = 0.03)。高敏感性不能预测疼痛,但可以预测健康相关的生活质量。结论:我们的研究结果表明,SPS是青少年慢性疼痛的一个重要和普遍的特征,特别是关于生活质量。
{"title":"Sensory processing sensitivity in adolescents reporting chronic pain: an exploratory study.","authors":"Helen Koechlin, Carolina Donado, Cosima Locher, Joe Kossowsky, Francesca Lionetti, Michael Pluess","doi":"10.1097/PR9.0000000000001053","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001053","url":null,"abstract":"<p><strong>Introduction: </strong>Sensory processing sensitivity (SPS) describes a genetically influenced trait characterized by greater <i>depth</i> of information <i>processing</i>, lower sensory threshold, and ease of overstimulation. It is hypothesized that SPS plays a crucial role in the context of chronic pain.<b>Objectives:</b> This exploratory study examined SPS as a correlate of pain intensity and pain-related disability in a sample of adolescents reporting chronic pain.</p><p><strong>Methods: </strong>Adolescents reporting chronic pain were contacted through social media and through specialized pain clinics. Participants completed online questionnaires on their levels of SPS, pain features, emotion regulation, and quality of life. A series of analysis of variances (ANOVAs) were calculated to detect differences between 3 SPS groups (ie, high, medium, and low sensitivity) regarding emotion regulation, quality of life, and pain features. Multiple linear regressions were conducted to predict pain intensity, pain-related disability, and quality of life.</p><p><strong>Results: </strong>In total, 103 participants completed the survey (68.9% female, M<sub>age</sub> 17.9). Back pain was the most frequently reported pain location. Proportion of highly sensitive individuals was large (45.68%). The ANOVA revealed significant differences between sensitivity groups related to quality-of-life subscales, namely, for physical (F(2, 100) = 7.42, <i>P</i> < 0.001), emotional (F(2, 100) = 6.11, <i>P</i> < 0.001), and school functioning (F(2, 100) = 3.75, <i>P</i> = 0.03). High sensitivity was not predictive of pain but of health-related quality of life.</p><p><strong>Conclusions: </strong>Our results indicate that SPS is an important and prevalent characteristic to consider in the context of chronic pain in adolescents, specifically regarding the quality of life.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1053"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10628789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Recent advances in stimulation techniques have improved the efficacy and expanded the applicability of spinal cord stimulation (SCS). Among these techniques, there are no reports on the efficacy of differential target multiplexed (DTM) SCS for chronic postsurgical pain (CPSP) after abdominal surgery. Therefore, we present the successful use of DTM SCS for CPSP after distal pancreatectomy.
Methods: A 49-year-old man with hypertension and severe chronic low back pain presented with neuropathic CPSP involving the left abdomen in the area of a laparotomy incision. His pain was refractory to conservative treatment and was rated 10 on a numerical rating scale (NRS). He underwent permanent implantation of a pulse generator after a 14-day trial stimulation.
Results: Chronic postsurgical pain was well controlled (NRS 1-2) at a 3-month follow-up with DTM SCS.
Conclusion: Differential target multiplexed SCS can be a new treatment option for neuropathic CPSP that is resistant to conservative treatment. It is important to further examine the characteristics of CPSP and identify appropriate candidates for the successful use of DTM SCS.
{"title":"Successful use of differential target multiplexed spinal cord stimulation for chronic postsurgical abdominal pain.","authors":"Ryusuke Tanaka, Kenji Shinohara, Yohei Hidai, Chiaki Kiuchi, Satoshi Tanaka, Mikito Kawamata, Junichi Sasao","doi":"10.1097/PR9.0000000000001059","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001059","url":null,"abstract":"<p><strong>Introduction: </strong>Recent advances in stimulation techniques have improved the efficacy and expanded the applicability of spinal cord stimulation (SCS). Among these techniques, there are no reports on the efficacy of differential target multiplexed (DTM) SCS for chronic postsurgical pain (CPSP) after abdominal surgery. Therefore, we present the successful use of DTM SCS for CPSP after distal pancreatectomy.</p><p><strong>Methods: </strong>A 49-year-old man with hypertension and severe chronic low back pain presented with neuropathic CPSP involving the left abdomen in the area of a laparotomy incision. His pain was refractory to conservative treatment and was rated 10 on a numerical rating scale (NRS). He underwent permanent implantation of a pulse generator after a 14-day trial stimulation.</p><p><strong>Results: </strong>Chronic postsurgical pain was well controlled (NRS 1-2) at a 3-month follow-up with DTM SCS.</p><p><strong>Conclusion: </strong>Differential target multiplexed SCS can be a new treatment option for neuropathic CPSP that is resistant to conservative treatment. It is important to further examine the characteristics of CPSP and identify appropriate candidates for the successful use of DTM SCS.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1059"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10623259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/PR9.0000000000001049
Juliane Sachau, Christina Appel, Maren Reimer, Manon Sendel, Jan Vollert, Philipp Hüllemann, Ralf Baron
Introduction: The sensory phenotype is believed to provide information about the underlying pathophysiological mechanisms and to be used in the diagnosis and treatment of chronic neuropathic pain. However, the use of standardized quantitative sensory testing (QST) protocols is limited due to high expenditures of time and costs. Thus, a simple bedside-QST battery was recently developed showing good agreement when compared with laboratory QST. The aim of this study was to preliminary validate this bedside-QST protocol.
Methods: Patients experiencing chronic pain with neuropathic features (n = 60) attended 3 visits. During the first visit, laboratory QST and bedside-QST were performed by the same trained investigator. Three hours and 3 weeks later, bedside-QST was repeated. Patients completed questionnaires regarding their pain (intensity, quality), depression/anxiety, and quality of life. Test-retest reliability and convergent/divergent validity were investigated.
Results: Most of the bedside-QST parameters, including also those recommended in our first study as being indicative for sensory phenotypes, revealed a moderate to excellent test-retest reliability. Overall, results for short-term reliability and interval-scaled parameters were slightly better. Most of the bedside-QST parameters did not correlate with the depression and anxiety score, suggesting a good divergent validity.
Conclusions: Bedside-QST has good criterion and divergent validity as well as reliability. This battery consists of 5 low-cost devices that can be quickly and easily used to characterize the sensory phenotype of patients with neuropathic pain. A combination of bedside-QST parameters can be used to investigate patients' subgroups with specific pathophysiological mechanisms and to identify treatment responders.
{"title":"Test-retest reliability of a simple bedside-quantitative sensory testing battery for chronic neuropathic pain.","authors":"Juliane Sachau, Christina Appel, Maren Reimer, Manon Sendel, Jan Vollert, Philipp Hüllemann, Ralf Baron","doi":"10.1097/PR9.0000000000001049","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001049","url":null,"abstract":"<p><strong>Introduction: </strong>The sensory phenotype is believed to provide information about the underlying pathophysiological mechanisms and to be used in the diagnosis and treatment of chronic neuropathic pain. However, the use of standardized quantitative sensory testing (QST) protocols is limited due to high expenditures of time and costs. Thus, a simple bedside-QST battery was recently developed showing good agreement when compared with laboratory QST. The aim of this study was to preliminary validate this bedside-QST protocol.</p><p><strong>Methods: </strong>Patients experiencing chronic pain with neuropathic features (n = 60) attended 3 visits. During the first visit, laboratory QST and bedside-QST were performed by the same trained investigator. Three hours and 3 weeks later, bedside-QST was repeated. Patients completed questionnaires regarding their pain (intensity, quality), depression/anxiety, and quality of life. Test-retest reliability and convergent/divergent validity were investigated.</p><p><strong>Results: </strong>Most of the bedside-QST parameters, including also those recommended in our first study as being indicative for sensory phenotypes, revealed a moderate to excellent test-retest reliability. Overall, results for short-term reliability and interval-scaled parameters were slightly better. Most of the bedside-QST parameters did not correlate with the depression and anxiety score, suggesting a good divergent validity.</p><p><strong>Conclusions: </strong>Bedside-QST has good criterion and divergent validity as well as reliability. This battery consists of 5 low-cost devices that can be quickly and easily used to characterize the sensory phenotype of patients with neuropathic pain. A combination of bedside-QST parameters can be used to investigate patients' subgroups with specific pathophysiological mechanisms and to identify treatment responders.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1049"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/31/painreports-8-e1049.PMC9842225.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10551746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/PR9.0000000000001052
Arunangshu Ghoshal, Shivam Bhanvadia, Som Singh, Lauren Yaeger, Simon Haroutounian
Studies have identified demographic, clinical, psychosocial, and perioperative variables associated with persistent pain after a variety of surgeries. This study aimed to perform a systematic review and meta-analysis of factors associated with persistent pain after total knee replacement (TKR) and total hip replacement (THR) surgeries. To meet the inclusion criteria, studies were required to assess variables before or at the time of surgery, include a persistent postsurgical pain (PPSP) outcome measure at least 2 months after a TKR or THR surgery, and include a statistical analysis of the effect of the risk factor(s) on the outcome measure. Outcomes from studies implementing univariate and multivariable statistical models were analyzed separately. Where possible, data from univariate analyses on the same factors were combined in a meta-analysis. Eighty-one studies involving 171,354 patients were included in the review. Because of the heterogeneity of assessment methods, only 44% of the studies allowed meaningful meta-analysis. In meta-analyses, state anxiety (but not trait anxiety) scores and higher depression scores on the Beck Depression Inventory were associated with an increased risk of PPSP after TKR. In the qualitative summary of multivariable analyses, higher preoperative pain scores were associated with PPSP after TKR or THR. This review systematically assessed factors associated with an increased risk of PPSP after TKR and THR and highlights current knowledge gaps that can be addressed by future research.
{"title":"Factors associated with persistent postsurgical pain after total knee or hip joint replacement: a systematic review and meta-analysis.","authors":"Arunangshu Ghoshal, Shivam Bhanvadia, Som Singh, Lauren Yaeger, Simon Haroutounian","doi":"10.1097/PR9.0000000000001052","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001052","url":null,"abstract":"<p><p>Studies have identified demographic, clinical, psychosocial, and perioperative variables associated with persistent pain after a variety of surgeries. This study aimed to perform a systematic review and meta-analysis of factors associated with persistent pain after total knee replacement (TKR) and total hip replacement (THR) surgeries. To meet the inclusion criteria, studies were required to assess variables before or at the time of surgery, include a persistent postsurgical pain (PPSP) outcome measure at least 2 months after a TKR or THR surgery, and include a statistical analysis of the effect of the risk factor(s) on the outcome measure. Outcomes from studies implementing univariate and multivariable statistical models were analyzed separately. Where possible, data from univariate analyses on the same factors were combined in a meta-analysis. Eighty-one studies involving 171,354 patients were included in the review. Because of the heterogeneity of assessment methods, only 44% of the studies allowed meaningful meta-analysis. In meta-analyses, state anxiety (but not trait anxiety) scores and higher depression scores on the Beck Depression Inventory were associated with an increased risk of PPSP after TKR. In the qualitative summary of multivariable analyses, higher preoperative pain scores were associated with PPSP after TKR or THR. This review systematically assessed factors associated with an increased risk of PPSP after TKR and THR and highlights current knowledge gaps that can be addressed by future research.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1052"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10628787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/PR9.0000000000001056
Jennifer S Lewis, Muhammad Kashif, Aasam Maan, Daniel Ciampi de Andrade, Michelle Casey, Jee Youn Moon, Chih-Peng Lin, Lena Danielsson, Terence Quek, Rodrigo Díez Tafur, Abdelkarim Aloweidi, Frank Birklein, Lone Knudsen, Andreas Goebel
The aim of this IASP complex regional pain syndrome (CRPS) SIG Global Series 2021 was to bring together clinicians including those from developing countries to better understand the clinical presentation of complex regional pain syndrome in countries with less well-published patient populations. The purpose was to learn from each other about the range of treatments, successful outcomes, and challenges experienced. These meeting proceedings comprise abstracts from nine countries that span 4 continents and are summaries of online presentations delivered by speakers representing these countries over the course of 2 symposia. The symposia were attended by a global audience of approximately 360 people. Patients with CRPS were described and treated by clinicians from countries across Asia (Pakistan, Jordan, South Korea, Taiwan, and Singapore), South America (Brazil and Peru), Africa (South Africa), and Europe (Norway). This reflects that CRPS exists across borders, ethnicities, and cultures. These proceedings provide a broader perspective within the international pain community about how we can better understand and treat CRPS across the globe.
{"title":"Global series: Complex regional pain syndrome: abstracts from the International Association for the Study of Pain complex regional pain syndrome SIG virtual symposia 2021.","authors":"Jennifer S Lewis, Muhammad Kashif, Aasam Maan, Daniel Ciampi de Andrade, Michelle Casey, Jee Youn Moon, Chih-Peng Lin, Lena Danielsson, Terence Quek, Rodrigo Díez Tafur, Abdelkarim Aloweidi, Frank Birklein, Lone Knudsen, Andreas Goebel","doi":"10.1097/PR9.0000000000001056","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001056","url":null,"abstract":"<p><p>The aim of this IASP complex regional pain syndrome (CRPS) SIG Global Series 2021 was to bring together clinicians including those from developing countries to better understand the clinical presentation of complex regional pain syndrome in countries with less well-published patient populations. The purpose was to learn from each other about the range of treatments, successful outcomes, and challenges experienced. These meeting proceedings comprise abstracts from nine countries that span 4 continents and are summaries of online presentations delivered by speakers representing these countries over the course of 2 symposia. The symposia were attended by a global audience of approximately 360 people. Patients with CRPS were described and treated by clinicians from countries across Asia (Pakistan, Jordan, South Korea, Taiwan, and Singapore), South America (Brazil and Peru), Africa (South Africa), and Europe (Norway). This reflects that CRPS exists across borders, ethnicities, and cultures. These proceedings provide a broader perspective within the international pain community about how we can better understand and treat CRPS across the globe.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1056"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/6b/painreports-8-e1056.PMC9845011.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9281799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/PR9.0000000000001061
Emelie Andersson, Thomas Kander, Mads U Werner, Joshua H Cho, Eva Kosek, Martin F Bjurström
Dysregulation of sleep heightens pain sensitivity and may contribute to pain chronification. Interventions which consolidate and lengthen sleep have the potential to improve pain control. The main objective of this systematic review was to examine the effects of sleep-promoting pharmacotherapy on pain intensity in patients with chronic pain. Multiple electronic databases were searched from inception to January 2022 to identify relevant randomized controlled trials (RCTs). Two independent reviewers screened titles, abstracts, and full-text articles; extracted data; and assessed risk of bias for each included study. The GRADE approach was used to determine the strength of evidence. The search identified 624 articles. After full-text screening, 10 RCTs (n = 574 randomized participants) involving 3 pharmacologic interventions (melatonin, zopiclone, and eszopiclone) and 7 different chronic pain populations were included. Minimum clinically significant pain reduction ≥30% was reported in 4 studies. There is low-quality evidence (downgraded due to inconsistency and imprecision) that 2 to 8 weeks treatment with a sleep-promoting medication alone or in combination with an analgesic (6 trials, n = 397) decreases pain intensity compared with placebo or the same analgesic treatment alone (SMD -0.58 [95% confidence interval -1.00, -0.17], P = 0.006). Analyses of associations between changes in sleep and pain outcomes were only provided in 2 articles, with inconsistent findings. Notably, pain-relieving effects were most consistent in melatonin trials. Only 3 studies implemented polysomnography to obtain objective sleep measures. Low-quality evidence indicates that pharmacologic sleep promotion may decrease pain intensity in chronic pain populations. More research is needed to fully understand the influence of sleep-targeting interventions on pain control.
{"title":"Analgesic efficacy of sleep-promoting pharmacotherapy in patients with chronic pain: a systematic review and meta-analysis.","authors":"Emelie Andersson, Thomas Kander, Mads U Werner, Joshua H Cho, Eva Kosek, Martin F Bjurström","doi":"10.1097/PR9.0000000000001061","DOIUrl":"https://doi.org/10.1097/PR9.0000000000001061","url":null,"abstract":"<p><p>Dysregulation of sleep heightens pain sensitivity and may contribute to pain chronification. Interventions which consolidate and lengthen sleep have the potential to improve pain control. The main objective of this systematic review was to examine the effects of sleep-promoting pharmacotherapy on pain intensity in patients with chronic pain. Multiple electronic databases were searched from inception to January 2022 to identify relevant randomized controlled trials (RCTs). Two independent reviewers screened titles, abstracts, and full-text articles; extracted data; and assessed risk of bias for each included study. The GRADE approach was used to determine the strength of evidence. The search identified 624 articles. After full-text screening, 10 RCTs (n = 574 randomized participants) involving 3 pharmacologic interventions (melatonin, zopiclone, and eszopiclone) and 7 different chronic pain populations were included. Minimum clinically significant pain reduction ≥30% was reported in 4 studies. There is low-quality evidence (downgraded due to inconsistency and imprecision) that 2 to 8 weeks treatment with a sleep-promoting medication alone or in combination with an analgesic (6 trials, n = 397) decreases pain intensity compared with placebo or the same analgesic treatment alone (SMD -0.58 [95% confidence interval -1.00, -0.17], <i>P</i> = 0.006). Analyses of associations between changes in sleep and pain outcomes were only provided in 2 articles, with inconsistent findings. Notably, pain-relieving effects were most consistent in melatonin trials. Only 3 studies implemented polysomnography to obtain objective sleep measures. Low-quality evidence indicates that pharmacologic sleep promotion may decrease pain intensity in chronic pain populations. More research is needed to fully understand the influence of sleep-targeting interventions on pain control.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"8 1","pages":"e1061"},"PeriodicalIF":4.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/9c/painreports-8-e1061.PMC9829257.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10628788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}